Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod 5% Cream for Periocular Basal Cell Carcinoma
NCT00803907Phase 4Unknown
- Sponsor
- Universidade de São Paulo
- Start
- Dec 2008
- Primary completion
- Sep 2012
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of imiquimod in basal cell carcinoma (BCC), sponsored by Universidade de São Paulo. Status: unknown.
02
Drugs
imiquimod
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT00803907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00803907.